A Phase 1, Open-label Study of [14C] NS-580 Following a Single Oral Dose in Healthy Male Subjects

• Research type

  Research Study

• Full title

  A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-NS-580 Following a Single Oral Dose in Healthy Male Subjects

• IRAS ID

  1007384

• Contact name

  Publication of this data is currently deferred.

• Contact email

  Publication of this data is currently deferred.

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  Publication of this data is currently deferred.

• Clinicaltrials.gov Identifier

  NCT06670898

• Clinicaltrials.gov Identifier

  Publication of this data is currently deferred.

• Research summary

  Publication of this data is currently deferred.

• REC name

  East of England - Cambridge Central Research Ethics Committee

• REC reference

  23/EE/0196

• Date of REC Opinion

  25 Oct 2023

• REC opinion

  Further Information Favourable Opinion